I've exhausted my query_library_db calls. I have enough context from the library snippets and my training knowledge to provide comprehensive answers to all 12 questions. Let me now compile detailed answers.Here are detailed answers to all 12 questions:
NARAYANA MEDICAL COLLEGE — Biochemistry 2nd Internal Assessment
ESSAY QUESTIONS (15 marks each)
Q1. Vitamin D: Synthesis, Biochemical Functions, Daily Requirement, Sources, and Deficiency Manifestations
Structure
Vitamin D is a fat-soluble steroid hormone. The two main forms are:
- Vitamin D₂ (Ergocalciferol) — from plants/fungi
- Vitamin D₃ (Cholecalciferol) — from animal sources and skin synthesis
Synthesis of Vitamin D (Step-by-step)
7-Dehydrocholesterol (in skin)
↓ [UV light / sunlight, 290–315 nm]
Previtamin D₃ → Vitamin D₃ (Cholecalciferol)
↓ [Liver: 25-hydroxylase / CYP27A1]
25-Hydroxycholecalciferol [25(OH)D₃] — major storage form
↓ [Kidney: 1α-hydroxylase / CYP27B1] ← PTH stimulates; Ca²⁺ inhibits
1,25-Dihydroxycholecalciferol [1,25(OH)₂D₃]
= CALCITRIOL — the active form
Regulation:
- PTH ↑ → activates renal 1α-hydroxylase → more calcitriol
- Low serum Ca²⁺/PO₄³⁻ → stimulates calcitriol production
- 24,25-dihydroxycholecalciferol is the inactive/storage metabolite (formed by 24-hydroxylase)
Daily Requirement
| Group | Requirement |
|---|
| Adults (19–70 yrs) | 600 IU/day (15 µg/day) |
| Elderly (>70 yrs) | 800 IU/day (20 µg/day) |
| Infants | 400 IU/day |
| Pregnancy/Lactation | 600 IU/day |
Dietary Sources
| Source | Content |
|---|
| Cod liver oil | Richest source |
| Fatty fish (salmon, mackerel, tuna) | High |
| Egg yolk, liver | Moderate |
| Fortified milk, cereals | Variable |
| Sunlight | Major endogenous source (15–30 min/day) |
Biochemical Functions of Vitamin D (Calcitriol)
-
Intestinal Ca²⁺ absorption:
- Calcitriol binds to nuclear VDR (Vitamin D Receptor)
- Induces synthesis of Calbindin-D (calcium-binding protein)
- Increases transcellular absorption of Ca²⁺ and phosphate from gut
-
Bone mineralization:
- Promotes osteoblast activity and calcium deposition
- Maintains adequate serum Ca²⁺ × PO₄³⁻ product for hydroxyapatite formation
- At high doses: promotes osteoclast activity → bone resorption
-
Renal reabsorption:
- Enhances reabsorption of Ca²⁺ and phosphate in distal tubules
-
Parathyroid gland:
- Suppresses PTH synthesis (negative feedback)
-
Immunomodulation:
- Activates macrophages; anti-inflammatory; reduces risk of autoimmune diseases
-
Cell differentiation:
- Promotes differentiation and inhibits proliferation (anticancer role)
-
Muscle function:
- Required for normal muscle contraction; deficiency causes myopathy
Deficiency Manifestations
In Children — RICKETS
- Defective mineralization of growing bones
- Craniotabes (softening of skull)
- Frontal bossing (prominent forehead)
- Rachitic rosary (beading at costochondral junctions)
- Harrison's sulcus (horizontal groove at diaphragm)
- Bow legs (genu varum) or knock knees (genu valgum)
- Widened epiphyses (wrist widening — "rickety rosary of wrist")
- Delayed dentition; dental caries
- Hypocalcemia → tetany, convulsions
In Adults — OSTEOMALACIA
- Softening of bones due to inadequate mineralization
- Bone pain, muscle weakness, fractures
- Looser zones (pseudo-fractures) on X-ray
- Waddling gait
Biochemical findings in rickets/osteomalacia:
- ↓ Serum Ca²⁺, ↓ Serum PO₄³⁻
- ↑ Serum Alkaline Phosphatase (ALP)
- ↑ PTH
Other deficiency effects:
- Osteoporosis (elderly)
- Increased susceptibility to infections
- Muscle weakness (proximal myopathy)
Q2. Metabolism of Phenylalanine and Tyrosine; Biologically Important Products; Inborn Errors
Overview
Both phenylalanine (essential) and tyrosine (non-essential if Phe is adequate) are aromatic amino acids. Phenylalanine is converted to tyrosine as the first step in its catabolism.
Metabolism Pathway
Phenylalanine
↓ [Phenylalanine hydroxylase + BH4 (tetrahydrobiopterin)]
Tyrosine
├──→ Catecholamines (DOPA → Dopamine → Norepinephrine → Epinephrine)
├──→ Thyroid hormones (T3, T4)
├──→ Melanin (via DOPA → Dopaquinone → Melanin)
├──→ Fumarate + Acetoacetate (energy catabolism)
└──→ Homogentisate pathway
Catabolism (convergent pathway):
Tyrosine
↓ [Tyrosine aminotransferase]
p-Hydroxyphenylpyruvate
↓ [p-hydroxyphenylpyruvate dioxygenase]
Homogentisate
↓ [Homogentisate oxidase]
Maleylacetoacetate
↓
Fumarylacetoacetate
↓
Fumarate + Acetoacetate (→ TCA cycle + ketone bodies)
Phenylalanine and tyrosine are both glucogenic AND ketogenic.
Biologically Important Products
| Product | Derived From | Function |
|---|
| Tyrosine | Phenylalanine | Protein synthesis; precursor for multiple products |
| Dopamine | Tyrosine (via DOPA) | Neurotransmitter; reward pathway |
| Norepinephrine | Dopamine | Neurotransmitter; fight-or-flight |
| Epinephrine (Adrenaline) | Norepinephrine | Hormone; glycogenolysis, lipolysis |
| Thyroxine (T₄) | Tyrosine + iodine | Thyroid hormone; regulates BMR |
| Triiodothyronine (T₃) | T₄ deiodination | Active thyroid hormone |
| Melanin | Tyrosine → DOPA | Skin/hair/eye pigment; photoprotection |
| Fumarate | Tyrosine catabolism | TCA cycle intermediate |
| Acetoacetate | Tyrosine catabolism | Ketone body |
Catecholamine synthesis pathway:
Tyrosine → [Tyrosine hydroxylase, BH4] → DOPA
→ [DOPA decarboxylase] → Dopamine
→ [Dopamine β-hydroxylase] → Norepinephrine
→ [PNMT, SAM] → Epinephrine
Inborn Errors of Metabolism
| Disease | Enzyme Defect | Accumulated Metabolite | Features |
|---|
| Phenylketonuria (PKU) | Phenylalanine hydroxylase (PAH) | Phenylalanine, phenylpyruvate, phenyllactate | Intellectual disability, musty odor, fair skin/hair, eczema; treat: low-Phe diet + tyrosine supplementation |
| Malignant PKU | BH4 synthesis or regeneration enzymes (GTP cyclohydrolase, DHPR) | Phenylalanine + ↓neurotransmitters | Severe neurological deficit; BH4 + neurotransmitter precursors needed |
| Tyrosinemia Type I | Fumarylacetoacetase | Fumarylacetoacetate, succinylacetone | Liver failure, hepatocellular carcinoma; treat: NTBC |
| Tyrosinemia Type II (Richner-Hanhart) | Tyrosine aminotransferase | Tyrosine | Palmoplantar keratosis, corneal ulcers, intellectual disability |
| Alkaptonuria | Homogentisate oxidase | Homogentisic acid | Urine turns black on standing, ochronosis (blue-black pigmentation in connective tissue), arthritis |
| Albinism | Tyrosinase (or related) | None accumulates | Absence of melanin; photophobia, nystagmus, pale skin/hair/eyes |
SHORT ESSAY QUESTIONS (10 marks each)
Q3. Products Obtained from Glycine
Glycine is the simplest amino acid (no chiral center) and is a major metabolic precursor:
1. Heme (Porphyrins)
- Glycine + Succinyl-CoA → δ-Aminolevulinic acid (ALA) [by ALA synthase, rate-limiting; requires pyridoxal phosphate]
- 8 ALA → Protoporphyrin IX → Heme (with Fe²⁺)
2. Purines
- Glycine contributes C4, C5, N7 of the purine ring
- Essential for de novo purine synthesis
3. Glutathione (GSH)
- Tripeptide: Glu–Cys–Gly
- Glycine is the third amino acid
- Key antioxidant
4. Creatine
- Glycine + Arginine → Guanidinoacetate [in kidney]
- Guanidinoacetate + methyl group (from SAM) → Creatine [in liver]
- Creatine → Creatine phosphate (energy storage in muscle)
5. Conjugated Bile Acids
- Cholic acid + Glycine → Glycocholic acid (bile salt)
- Facilitates fat digestion/absorption
6. Hippuric Acid
- Benzoic acid + Glycine → Hippuric acid
- Detoxification product; excreted in urine
7. Serine and One-Carbon Units
- Glycine ↔ Serine (reversible; serine hydroxymethyltransferase + THF)
- Provides 1-carbon units for methylation reactions
8. Glycine as Neurotransmitter
- Inhibitory neurotransmitter in spinal cord and brainstem
9. Glyoxylate and Oxalate
- Glycine → Glyoxylate → Oxalate (risk for kidney stones if excess)
10. Collagen
- Glycine is every third residue in collagen (Gly-X-Y repeat) — essential for triple helix structure
Q4. Purine Catabolism
Purines (Adenine and Guanine) from nucleic acid degradation are catabolized to uric acid in humans.
Pathway
AMP GMP
↓ [5'-nucleotidase] ↓ [5'-nucleotidase]
Adenosine Guanosine
↓ [Adenosine deaminase] ↓ [Purine nucleoside phosphorylase]
Inosine Guanine
↓ [Purine nucleoside ↓ [Guanase/Guanine deaminase]
phosphorylase]
Hypoxanthine Xanthine
↘ ↗
[Xanthine oxidase]
Xanthine
↓ [Xanthine oxidase]
Uric Acid (end product)
Key enzyme: Xanthine oxidase (requires molybdenum as cofactor)
Uric Acid
- End product in humans, great apes, Dalmatian dogs
- Other mammals have uricase → allantoin → urea
- Normal serum uric acid: Men: 3.5–7.2 mg/dL; Women: 2.6–6.0 mg/dL
- Excreted mainly by kidneys (~70%) and gut (~30%)
Clinical Significance
| Condition | Mechanism | Features |
|---|
| Gout | Hyperuricemia → monosodium urate crystals in joints | Acute painful arthritis (1st MTP joint), tophi, nephropathy |
| Lesch-Nyhan Syndrome | HGPRT deficiency → ↑↑ uric acid | Self-mutilation, choreoathetosis, gout (see Q11) |
| Allopurinol (drug) | Inhibits xanthine oxidase | Treats gout by reducing uric acid |
Salvage Pathway (recap)
- HGPRT: Hypoxanthine + PRPP → IMP; Guanine + PRPP → GMP
- APRT: Adenine + PRPP → AMP
- Saves energy vs. de novo synthesis
Q5. Iron Absorption and Mucosal Block Theory
Forms of dietary iron
- Haem iron (Fe²⁺ in heme) — from meat; 20–30% absorbed; direct uptake via HCP1
- Non-haem iron (Fe³⁺) — from plants; 1–5% absorbed; must be reduced to Fe²⁺ first
Steps of Iron Absorption
LUMEN ENTEROCYTE BLOOD
Fe³⁺ [dietary]
↓ [Duodenal cytochrome b (DcytB), vitamin C helps]
Fe²⁺
↓ [DMT-1 (Divalent Metal Transporter 1)]
Fe²⁺ in enterocyte
↙ ↘
[stored as Ferritin] [Ferroportin → exports Fe²⁺]
↓ [Hephaestin, copper-enzyme]
Fe³⁺
↓ [Transferrin in plasma]
Transferrin-Fe³⁺ complex
Mucosal Block Theory (Hahn, 1943)
- Proposed that the intestinal mucosal cell acts as a "block" to prevent iron overload
- When iron stores are replete:
- Intracellular ferritin levels rise in enterocytes
- Incoming Fe²⁺ is stored as ferritin rather than exported
- When the enterocyte is shed (every 3–5 days), stored iron is lost
- This limits further absorption → "mucosal block"
- When body needs more iron:
- Ferritin synthesis decreases
- More iron is exported via ferroportin
- Hepcidin (from liver) is the master regulator:
- ↑ Hepcidin → degrades ferroportin → blocks iron export → reduces absorption
- ↑ Iron stores, infection, inflammation → ↑ Hepcidin
- ↓ Iron stores, hypoxia, erythropoiesis → ↓ Hepcidin
Factors enhancing absorption
- Ascorbic acid (Vitamin C) — reduces Fe³⁺ → Fe²⁺
- HCl (gastric acid) — keeps iron soluble
- Meat factor
- Low body iron stores
Factors reducing absorption
- Phytates (cereals), oxalates (spinach)
- Phosphates, tannins (tea/coffee)
- Antacids (↑ pH)
- ↑ Body iron stores (via hepcidin)
Q6. Functions of Glutathione
Structure: Tripeptide — γ-Glutamyl–Cysteinyl–Glycine (GSH)
- The sulfhydryl (–SH) group of cysteine is the active site
- Exists in reduced (GSH) and oxidized (GSSG) forms
- GSH:GSSG ratio normally >10:1 in cells
- Regenerated by Glutathione reductase using NADPH
Functions
-
Antioxidant (primary role)
- 2 GSH + H₂O₂ → GSSG + 2H₂O [by Glutathione peroxidase]
- Neutralizes free radicals and reactive oxygen species (ROS)
-
Protection of RBCs
- Reduces oxidized hemoglobin (MetHb → Hb)
- Maintains membrane protein thiols
- Deficiency of G6PD → ↓ NADPH → ↓ GSH → RBC hemolysis (G6PD deficiency)
-
Detoxification / Conjugation
- GSH conjugates with xenobiotics (drugs, carcinogens) in Phase II liver detoxification
- GSH + Paracetamol toxic metabolite (NAPQI) → safe conjugate
- Mercapturic acid pathway
-
Amino acid transport (γ-glutamyl cycle)
- γ-Glutamyl transpeptidase transfers Glu from GSH to amino acids on cell surface
- Transports amino acids across cell membranes (especially kidney, intestine)
- Meister cycle — active transport of amino acids
-
Reduction of ribonucleotides
- Ribonucleotide reductase uses glutaredoxin (reduced by GSH) to make deoxyribonucleotides
-
Maintenance of protein –SH groups
- Keeps enzyme active-site cysteines in reduced (active) state
-
Leukotriene synthesis
- GSH is substrate for leukotriene (eicosanoid) synthesis
-
Sperm function
- High GSH in sperm; protects from oxidative damage
Q7. Van Den Berg Reaction
Definition
The Van den Bergh reaction (1916) is a chemical test to measure serum bilirubin levels using Ehrlich's diazo reagent (diazotized sulfanilic acid).
Principle
- Bilirubin + Diazo reagent → Azobilirubin (purple-pink color)
- The reaction gives a pink/violet color measured at 540 nm
Types of Bilirubin
| Property | Direct Bilirubin | Indirect Bilirubin |
|---|
| Form | Conjugated (glucuronide) | Unconjugated |
| Solubility | Water-soluble | Lipid-soluble (bound to albumin) |
| Reaction | Reacts directly with diazo reagent without alcohol | Requires alcohol to react |
| Van den Bergh | Direct reaction | Indirect reaction |
| Crosses BBB | No | Yes (neurotoxic) |
Procedure
- Direct bilirubin (conjugated): Sample + diazo reagent → pink color in aqueous medium within 1 min
- Total bilirubin: Sample + methanol (alcohol) + diazo reagent → all bilirubin reacts
- Indirect bilirubin (unconjugated): Total − Direct
Normal Values
| Fraction | Normal value |
|---|
| Total bilirubin | 0.2–1.0 mg/dL |
| Direct (conjugated) | 0.0–0.2 mg/dL |
| Indirect (unconjugated) | 0.2–0.8 mg/dL |
Clinical Significance
| Type | Direct ↑ | Indirect ↑ |
|---|
| Cause | Obstructive jaundice, hepatocellular disease | Hemolytic jaundice, Gilbert's, Crigler-Najjar |
| Urine bilirubin | Present (bilirubinuria) | Absent |
| Stercobilinogen | Reduced (clay stools) | Increased |
| Kernicterus | Not caused | Risk in neonates (indirect crosses BBB) |
Q8. Products of Transmethylation
Definition
Transmethylation is the transfer of a methyl group (–CH₃) from a donor to an acceptor. The universal methyl donor is S-Adenosylmethionine (SAM) (also called "active methionine").
Formation of SAM
Methionine + ATP → S-Adenosylmethionine (SAM) [by Methionine adenosyltransferase]
Products of Transmethylation via SAM
| Methyl Acceptor | Product | Enzyme | Significance |
|---|
| Guanidinoacetate | Creatine | Guanidinoacetate methyltransferase | Energy storage in muscle |
| Norepinephrine | Epinephrine (Adrenaline) | PNMT (Phenylethanolamine-N-methyltransferase) | Adrenal hormone |
| Phosphatidylethanolamine | Phosphatidylcholine (Lecithin) | PE N-methyltransferase | Cell membrane phospholipid; VLDL synthesis |
| Acetylserotonin | Melatonin | HIOMT | Sleep hormone; circadian rhythm |
| Ethanolamine | Choline | — | Neurotransmitter precursor; lipid metabolism |
| DNA bases | Methylated DNA | DNA methyltransferase | Gene silencing, epigenetics |
| RNA bases | Methylated RNA | tRNA/rRNA methylases | tRNA stability |
| Histamine | Methylhistamine | Histamine methyltransferase | Histamine inactivation |
| Nicotinamide | N-Methylnicotinamide | Nicotinamide methyltransferase | Niacin catabolism |
| Homocysteine (re-methylation) | Methionine | Methionine synthase (B₁₂) | SAM regeneration |
After Methylation: SAM → SAH
SAM + Acceptor → SAH (S-Adenosylhomocysteine) + Methylated product
SAH → Adenosine + Homocysteine [by SAH hydrolase]
Homocysteine → Methionine [by methionine synthase, needs B₁₂ + folate]
or → Cystathionine → Cysteine [transsulfuration, needs B₆]
Q9. Calcium Homeostasis
Normal values
- Total serum calcium: 8.5–10.5 mg/dL (2.1–2.6 mmol/L)
- Ionized (free) Ca²⁺: 4.5–5.5 mg/dL (~50%)
- Protein-bound: ~40% (mainly albumin)
- Complexed: ~10%
Body distribution
- 99% in bone (hydroxyapatite)
- 1% in blood and soft tissues
Three Hormones Regulating Calcium
1. Parathyroid Hormone (PTH)
- Released when serum Ca²⁺ ↓
- Bone: ↑ Osteoclast activity → ↑ Ca²⁺ and PO₄³⁻ release
- Kidney: ↑ Ca²⁺ reabsorption (distal tubule); ↓ PO₄³⁻ reabsorption; activates 1α-hydroxylase → ↑ calcitriol
- Gut: Indirect (via calcitriol) → ↑ Ca²⁺ absorption
- Net: ↑ serum Ca²⁺, ↓ serum PO₄³⁻
2. Vitamin D (Calcitriol — 1,25(OH)₂D₃)
- Activated by PTH in kidney
- Gut: ↑ Ca²⁺ and PO₄³⁻ absorption (via calbindin-D synthesis)
- Bone: At physiological levels → promotes mineralization; at high levels → resorption
- Kidney: ↑ Ca²⁺ reabsorption
- Net: ↑ serum Ca²⁺ and PO₄³⁻
3. Calcitonin
- Released from parafollicular (C) cells of thyroid when Ca²⁺ ↑
- Bone: ↓ Osteoclast activity → ↓ Ca²⁺ release
- Kidney: ↑ Ca²⁺ and PO₄³⁻ excretion
- Net: ↓ serum Ca²⁺ (opposes PTH)
Summary diagram:
Low Ca²⁺ → ↑PTH → ↑ Bone resorption, ↑ Renal Ca²⁺ reabsorption, ↑ Calcitriol
↓
↑ Gut absorption (calcitriol)
↓
↑ Serum Ca²⁺ → negative feedback → ↓ PTH; ↑ Calcitonin
Clinical Disorders
| Disorder | Mechanism | Features |
|---|
| Hypocalcemia | ↓ PTH, ↓ Vit D, ↓ Mg²⁺ | Tetany, Trousseau's, Chvostek's, convulsions |
| Hypercalcemia | ↑ PTH (hyperparathyroidism), malignancy | Stones, bones, groans, moans (renal stones, bone pain, constipation, confusion) |
| Rickets/Osteomalacia | ↓ Vitamin D | (see Q1) |
Q10. Transmethylation and Deamination
A. TRANSMETHYLATION
(Detailed answer covered in Q8 above — brief summary here)
- Transfer of methyl group (–CH₃) from SAM to various acceptors
- SAM = "active methionine" (methionine + ATP)
- Products: creatine, epinephrine, phosphatidylcholine, melatonin, methylated DNA/RNA
SAM cycle:
Methionine + ATP → SAM → [Methylation] → SAH → Homocysteine → (back to Methionine via B₁₂/folate)
B. DEAMINATION
Deamination is the removal of an amino group (–NH₂) from amino acids, releasing ammonia (NH₃) and producing keto acids.
Types of Deamination:
1. Oxidative Deamination (most important)
Glutamate + NAD⁺ → α-Ketoglutarate + NH₃ + NADH
[Enzyme: Glutamate dehydrogenase, in liver mitochondria; requires NAD⁺ or NADP⁺]
- Allosteric inhibited by GTP, NADH (energy surplus)
- Activated by ADP, NAD⁺ (energy deficit)
- This is the major source of free ammonia for urea synthesis
2. Transamination (NOT true deamination, but linked)
Amino acid + α-Ketoglutarate → Keto acid + Glutamate [by aminotransferases, PLP]
Glutamate → deaminated by GDH → releases NH₃
3. Non-oxidative Deamination
- Serine → Pyruvate + NH₃ [serine dehydratase, B₆]
- Threonine → α-ketobutyrate + NH₃ [threonine dehydratase]
- Cysteine → Pyruvate + NH₃ + H₂S
4. Oxidase type (D-amino acids)
- D-amino acid oxidase: D-amino acids + O₂ → keto acid + NH₃ + H₂O₂
Fate of NH₃:
- In liver → Urea cycle (detoxification)
- In brain/peripheral tissues → Glutamine synthesis (Glu + NH₃ → Glutamine, by glutamine synthetase)
- In kidney → Excreted as NH₄⁺ (acid-base regulation)
Clinical: Hyperammonemia
- Urea cycle enzyme defects → toxic accumulation of NH₃
- Symptoms: encephalopathy, vomiting, cerebral edema, coma
- NH₃ depletes α-ketoglutarate → TCA cycle impaired
Q11. Lesch-Nyhan Syndrome and Orotic Aciduria
A. LESCH-NYHAN SYNDROME
Definition: X-linked recessive disorder of purine metabolism.
Enzyme defect: Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT) — complete absence
Gene: HPRT1 gene on X chromosome
Mechanism:
- HGPRT normally salvages hypoxanthine and guanine back to IMP and GMP
- In its absence, hypoxanthine and guanine cannot be recycled
- PRPP accumulates → drives de novo purine synthesis → excess purine catabolism → ↑↑ Uric acid
- Loss of IMP/GMP feedback → unregulated PRPP amidotransferase
Features:
| Feature | Details |
|---|
| Hyperuricemia | Gout, uric acid stones, renal failure |
| Self-mutilation | Compulsive biting of fingers, lips, and buccal mucosa — pathognomonic |
| Neurological | Choreoathetosis, spasticity, intellectual disability, dystonia |
| Onset | 3–6 months; appears normal at birth |
| Inheritance | X-linked recessive (males affected, females carriers) |
Laboratory: ↑↑ Uric acid, absent HGPRT activity in RBCs/fibroblasts
Treatment:
- Allopurinol — reduces uric acid (controls gout/stones but NOT neurological symptoms)
- No cure; neurological damage is irreversible
B. OROTIC ACIDURIA
Definition: Inborn error of pyrimidine (not purine) de novo synthesis.
Types:
| Type | Enzyme Defect | Features |
|---|
| Type I (Classic) | UMP synthase (bifunctional enzyme: OPRT + ODC) — both activities absent | Most common type |
| Type II | ODC (orotidine decarboxylase) only — OPRT activity present | Very rare |
Mechanism:
- Orotic acid is an intermediate in pyrimidine synthesis pathway
- CAD → Orotic acid → [OPRT] → Orotidine-5'-phosphate → [ODC] → UMP
- Enzyme defect → orotic acid cannot proceed → accumulates → excreted in urine
Also caused by:
- OTC (ornithine transcarbamylase) deficiency — accumulated carbamoyl phosphate is shunted into pyrimidine pathway → orotic acid overflow
- Allopurinol therapy (minor orotic aciduria)
Clinical Features:
- Megaloblastic anemia (not responsive to B₁₂ or folate)
- Failure to thrive, growth retardation
- Crystalluria (orotic acid crystals in urine)
- Developmental delay (if untreated)
- No hyperammonemia (distinguishes from OTC deficiency)
Diagnosis:
- Elevated orotic acid in urine
- Megaloblastic anemia unresponsive to B₁₂/folate
Treatment:
- Uridine supplementation (bypasses the block)
- Uridine → UMP → UTP → CTP (pyrimidines replenished)
- UTP feedback-inhibits carbamoyl phosphate synthetase → reduces orotic acid accumulation
Q12. Urea Cycle — Illustrative Diagram
The Urea Cycle occurs mainly in liver hepatocytes (mitochondria + cytoplasm). It converts toxic NH₃ to non-toxic urea for excretion by kidneys.
Enzymes, substrates, and products:
MITOCHONDRIA
┌────────────────────────────────┐
│ │
NH₃ + CO₂ │ │
(from GDH) │ │
↓ │ │
Carbamoyl phosphate │
[CPS-I: Carbamoyl ← 2 ATP │
Phosphate ← H₂O │
Synthetase I] ← N-acetylglutamate (activator) │
↓ │ │
Carbamoyl phosphate + Ornithine │
↓ [OTC: Ornithine Transcarbamylase] │
CITRULLINE │
│ └────────────────────────────────┘
│ (exits mitochondria via transporter)
↓
CYTOPLASM
CITRULLINE + Aspartate (ATP → AMP + PPᵢ)
↓ [ASS: Argininosuccinate Synthetase]
ARGININOSUCCINATE
↓ [ASL: Argininosuccinate Lyase]
ARGININE + Fumarate
| ↓ (→ TCA cycle → regenerates aspartate)
↓ [Arginase + H₂O]
ORNITHINE + UREA
|
↓ (Ornithine re-enters mitochondria)
Summary Table of Urea Cycle Reactions
| Step | Enzyme | Location | Reaction |
|---|
| 1 | Carbamoyl phosphate synthetase I (CPS-I) | Mitochondria | NH₃ + CO₂ + 2ATP → Carbamoyl phosphate |
| 2 | Ornithine transcarbamylase (OTC) | Mitochondria | Carbamoyl-P + Ornithine → Citrulline |
| 3 | Argininosuccinate synthetase (ASS) | Cytoplasm | Citrulline + Aspartate + ATP → Argininosuccinate |
| 4 | Argininosuccinate lyase (ASL) | Cytoplasm | Argininosuccinate → Arginine + Fumarate |
| 5 | Arginase | Cytoplasm | Arginine + H₂O → Ornithine + Urea |
Urea — key points:
- 2 nitrogen atoms in urea: one from NH₃ (glutamate deamination), one from aspartate
- 1 carbon from CO₂
- Net cost: 3 ATP (4 high-energy bonds) per urea molecule
- Urea is water-soluble; excreted by kidneys
- Blood urea nitrogen (BUN): normal 7–20 mg/dL
Inborn errors of the Urea Cycle:
| Enzyme Defect | Disease | Key Feature |
|---|
| CPS-I | CPS-I deficiency | ↓ All cycle intermediates |
| OTC | OTC deficiency (X-linked) | Most common; ↑ orotic acid (distinguishes from CPS-I deficiency) |
| ASS | Citrullinemia Type I | ↑ Citrulline |
| ASL | Argininosuccinic aciduria | ↑ Argininosuccinate; trichorrhexis nodosa |
| Arginase | Argininemia | ↑ Arginine; spastic diplegia |
All present with hyperammonemia, encephalopathy, vomiting.
---All 12 questions have been answered. Here is a quick navigation guide:
Quick Reference — All Questions Answered
| # | Topic | Key Takeaway |
|---|
| Q1 | Vitamin D | 7-dehydrocholesterol → Cholecalciferol (UV) → 25(OH)D₃ (liver) → 1,25(OH)₂D₃ (kidney/calcitriol); functions: Ca²⁺/PO₄ homeostasis; deficiency: rickets (children), osteomalacia (adults) |
| Q2 | Phe & Tyr metabolism | Phe → Tyr (PAH+BH4) → catecholamines/melanin/thyroid hormones/fumarate+acetoacetate; inborn errors: PKU, alkaptonuria, albinism, tyrosinemia |
| Q3 | Glycine products | Heme, purines, glutathione, creatine, conjugated bile acids, hippuric acid, serine, collagen, neurotransmitter |
| Q4 | Purine catabolism | AMP/GMP → Hypoxanthine/Xanthine → Uric acid (xanthine oxidase); clinical: gout, Lesch-Nyhan |
| Q5 | Iron absorption | Fe³⁺ → Fe²⁺ (DcytB) → DMT-1 → enterocyte → ferroportin → transferrin; mucosal block = ferritin storage when stores replete; hepcidin is master regulator |
| Q6 | Glutathione | Antioxidant (GPx), RBC protection, detoxification (Phase II), γ-glutamyl cycle (AA transport), NADPH-dependent regeneration |
| Q7 | Van den Berg | Tests bilirubin with diazo reagent; Direct = conjugated (water-soluble); Indirect = unconjugated (needs alcohol); differentiates jaundice types |
| Q8 | Transmethylation products | SAM is methyl donor → creatine, epinephrine, lecithin, melatonin, methylated DNA/RNA |
| Q9 | Calcium homeostasis | PTH (↑Ca²⁺), Calcitriol (↑Ca²⁺+PO₄), Calcitonin (↓Ca²⁺); 99% in bone; CaSR senses plasma Ca²⁺ |
| Q10 | Transmethylation & Deamination | SAM cycle (methylation); Oxidative deamination by GDH releases NH₃ for urea cycle |
| Q11 | Lesch-Nyhan & Orotic aciduria | HGPRT deficiency → ↑↑ uric acid + self-mutilation + neurological damage; Orotic aciduria = UMP synthase defect → megaloblastic anemia, treat with uridine |
| Q12 | Urea cycle | 5 steps (CPS-I → OTC → ASS → ASL → Arginase); mitochondria + cytoplasm; 3 ATP; 2 N atoms in urea |